Pseudomonas aeruginosa antibiotic resistance mechanisms are both innate and acquired, different according to the considered antibiotic; epidemiological follow-up of AB resistance for this pathogen is managed through ONERBA network (www.onerba.org); therapeutic approaches must limit resistant strains diffusion and resistant mutants emergence.